grouP O wholE blooD : storagE leSion impacT And infLammation
grouP O wholE blooD (LTO-WB): storagE leSion impacT And infLammation
Etablissement Français du Sang
30 participants
Mar 12, 2025
INTERVENTIONAL
Conditions
Summary
"Etablissement Français du Sang" (EFS) prepares labile blood products from blood donations that are separated by type (red blood cells, plasma and platelets). The "Centre de Transfusion Sanguine des Armées" (CTSA) produces an innovative labile blood product, LTO-WB, corresponding to group O leukocyte-free whole blood. The objective of the PEDESTAL EFS study is to compare the inflammatory and biological characteristics of blood products prepared by the EFS vs. the labile blood product prepared by the CTSA.
Eligibility
Inclusion Criteria3
- Be in good health
- Weigh at least 50 kg
- Must be between 18 and 70 years of age for whole blood donation and between 18 and 65 years of age for plasma/platelet donation by apheresis.
Exclusion Criteria1
- Subjects ineligible to donate blood
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This intervention involves the collection of a whole blood bag.
This procedure involves the collection of a plasma/platelets bag by apheresis
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06809010